Clinical Trial Update: Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Qishenyiqi Dripping Pills for chronic heart failure with preserved ejection fraction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Qishenyiqi Dripping Pills (Qishenyiqi dripping pills)

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Chronic Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED